Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants

ALXN2030OngoingActive not recruitingPhase 1Open NCT05501717 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT05501717 · Trial Tracker · ComplyRx